Social media part 2: Navigating the evolving landscape for doctorsDespite challenges, social media remains an important space where patients seek health information and physicians must adapt to engage. Social media part 1: Bye bye birdie While platforms like Bluesky now offer a promising alternative X/Twitter, none yet replicate the real-time conference reporting and global interaction that made Twitter indispensable in its prime. Poll: Is Dr. Elaine Ma being mistreated over demand she pay back $600,000? See what your colleagues say. Take our weekly doctor poll. The risk of groupthink in pandemic planning and preparedness If big bureaucracies can’t get important things right, what’s their value? The Dr. Elaine Ma case is proof that Ontario is unfriendly to physicians We need to support our healthcare heroes, not penalize them on technicalities in outdated bulletins. New product: Tyenne Get the info you need on this new product, part of our drug news roundup for December. New product: Nuvaxovid Get the info you need on this new product, part of our drug news roundup for December. New product: Comirnaty Get the info you need on this new product, part of our drug news roundup for December. Co-administration of COVID-19 and flu vaccine fine in autoimmune population Data presented at Canadian Immunization Conference show no increased risk of health events. The story of Alberta’s rural long COVID program that never was With the province closing its clinics dedicated to treating people with long COVID, the story of Alberta’s innovative rural outreach program appears destined to remain incomplete. First Previous 8 9 10 11 12 Next Last
